Cargando…
Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer: A Multicenter Phase 2 Study
No standard chemotherapy has been defined for metastatic breast cancer (MBC) patients pretreated with anthracyclines and taxanes. A multicenter phase 2 study was conducted to evaluate the safety and efficacy of oral etoposide in patients with MBC. Eligible patients were treated with repeated cycles...
Autores principales: | Yuan, Peng, Di, Lijun, Zhang, Xiaohui, Yan, Min, Wan, Donggui, Li, Li, Zhang, Yongqiang, Cai, Jufen, Dai, Hong, Zhu, Qi, Hong, Ruoxi, Xu, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603047/ https://www.ncbi.nlm.nih.gov/pubmed/25929919 http://dx.doi.org/10.1097/MD.0000000000000774 |
Ejemplares similares
-
Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer: A
Multicenter Phase 2 Study: Erratum
Publicado: (2015) -
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis
por: Su, Li, et al.
Publicado: (2017) -
Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015) -
Successful treatment of a patient with small cell lung cancer receiving hemodialysis, with concurrent oral etoposide and radiotherapy: A case report
por: Gao, Feng, et al.
Publicado: (2020) -
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)